Astilbin Chlorogenic Acid Composition for Urinary Infection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Recurrent urinary tract infections, particularly those caused by pathogens like E. coli, often lead to antibiotic resistance due to frequent use, and existing treatments fail to effectively manage inflammation and host defense mechanisms.
Innovation Solution
A composition comprising smilax glabra rhizome extracted astilbin and Flos Lonicerae extracted chlorogenic acid, along with other synergistic ingredients like pathogen isolators, urine pH stabilizers, matrix metalloproteinase inhibitors, and macrophage function modulators, is administered to reduce bacterial adherence, inflammation, and enhance host defense.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are frequently and repeatedly used to treat urinary system infections, then the infection is effectively treated, but antibiotic resistance develops
Solution Approach 1:
The invention segments the treatment approach by combining multiple natural compounds with different mechanisms of action (astilbin from Smilax glabra, chlorogenic acid from Flos Lonicerae, urolithin from fruits/nuts, andrographolide from Andrographis paniculata) to treat urinary infections. This multi-component strategy targets bacteria through various pathways simultaneously, reducing the likelihood of resistance development compared to single-antibiotic therapy.
Solution Approach 2:
The invention uses a composite formulation of multiple natural compounds extracted from different plant and food sources. Each component contributes unique anti-infective, anti-inflammatory, and immune-modulating properties, creating a synergistic effect that enhances treatment effectiveness while minimizing resistance induction through diverse mechanisms of action.
2Quantity of substance
If conventional treatments focus only on killing bacteria, then bacterial load is reduced, but inflammation and host defense mechanisms are not adequately managed
Solution Approach 1:
The invention employs multi-functional natural compounds that simultaneously perform multiple roles: astilbin and chlorogenic acid exhibit both antibacterial and anti-inflammatory activities; urolithin and andrographolide enhance host immune defense while maintaining anti-infective properties. This universal approach addresses bacterial elimination, inflammation control, and immune support within a single treatment regimen.
Solution Approach 2:
The invention merges three critical therapeutic functions into one composition: (1) direct antibacterial action against uropathogens, (2) anti-inflammatory effects to reduce tissue damage and discomfort, and (3) immune system enhancement to improve host defense. This integrated approach comprehensively manages the infection and its associated harmful effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively reduces the risk of recurrent urethritis and cystitis by inhibiting bacterial adherence, controlling inflammatory responses, and enhancing immune function, offering an alternative to antibiotics that minimizes resistance induction and provides anti-inflammatory benefits.
Implementation Method 1
inhibiting bacterial adherence
Implementation Method 2
macrophage function modulators
Implementation Method 3
matrix metalloproteinase inhibitors
Data Source
AI summary
The present invention relates to a method of reducing risk of recurrent urethritis or recurrent cystitis comprises administering to a patient with risk of recurrent urethritis or recurrent cystitis an effective amount of a composition consisting essentially of astilbin and chlorogenic acid.